ClinicalTrials.Veeva

Menu

Zip Incision Approximation vs. Suture for C-Section (ZIPS-C)

Z

Zipline Medical

Status

Unknown

Conditions

C.Surgical Procedure; Dehiscence, Cesarean Section

Treatments

Other: Conventional Sutures
Device: Zip Surgical Skin Closure Device

Study type

Interventional

Funder types

Industry

Identifiers

NCT02915952
ZipsC-006

Details and patient eligibility

About

The study will evaluate the ZipLine Medical Surgical Skin Closure device (Zip)versus sutures when utilized for skin layer closure during wound closure of Cesarean Section Procedure.

Full description

Cesarean-section birth is a very invasive surgical procedure. While the desired outcome focuses primarily on the successful delivery of a healthy baby and maintenance of the mother's health, the surgery involves a complex surgical closure process, starting with the uterus, and progressing through several layers of traditionally suture closure in several tissue planes. A successful closure results in no surgical site complications, with good patient comfort and a minimal scar being a desired outcome.

Conventional skin closure methods such as sutures are effective but have drawbacks. It has been suggested that the ideal method of wound / incision closure should be:

  • fast
  • non-traumatic
  • minimally or non-invasive
  • associated with a low incidence of adverse events such as dehiscence and infection
  • yielding acceptable cosmetic results

ZipLine Medical, Inc. is a Campbell, California-based company that has developed a novel, non-invasive skin closure device called Zip Surgical Skin Closure to replace sutures, staples and glue for closure of the skin layer for surgical incisions or laceration repair. In the USA, the device has been classified by the FDA as a Class I, 510(k) Exempt device and began commercial use in the USA in April 2013.

The ZipLine Device has been clinically demonstrated benefits include (references included later in this document):

  • Closure speed faster/superior to (and less variable compared to) sutures
  • Suture-like cosmetic outcome
  • Reduction in post-surgical care costs
  • Fewer closure-related wound issues
  • Greater patient satisfaction

Enrollment

60 estimated patients

Sex

All

Ages

18 to 55 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  1. Patients 18 years of age and older
  2. Primary C-section
  3. Patients willing and able to complete study protocol

Exclusion criteria

  1. Known bleeding disorder not caused by medication
  2. Known personal or family history of keloid formation or scar hypertrophy
  3. Known allergy or hypersensitivity to non-latex skin adhesives
  4. Atrophic skin deemed clinically prone to blistering
  5. Any skin disorder affecting wound healing
  6. Any other condition that in the opinion of the investigator would make a particular subject unsuitable for this study
  7. Emergent C-Section
  8. Non-primary C-Section

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

60 participants in 2 patient groups

Zip Closure Device
Active Comparator group
Description:
The Zip device is a non-invasive, single use, sterile medical device for closure of the skin layer for surgical incisions or laceration repair.
Treatment:
Device: Zip Surgical Skin Closure Device
Conventional Sutures
Active Comparator group
Description:
Conventional subdermal (subcuticular) absorbable sutures
Treatment:
Other: Conventional Sutures

Trial contacts and locations

1

Loading...

Central trial contact

Eric Storne; Wendy M Winters

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems